Business Standard
Monday, May 28, 2012
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
|||||||Mgmt & Mktg|| 
 Section Home | Guru Speak | Management | Marketing | Strategy | Kit | the strategist | Columnists | BSchools | Books & Ideas | People & Careers
Home > Mgmt & Mktg Live Markets | Commodities
 

Google agrees to pay $500 mn in drug-advertising settlement
Bloomberg / Washington Aug 25, 2011, 00:16 IST

Google Inc agreed to pay $500 million to settle US allegations that advertising for online Canadian pharmacies on its website allowed illegal imports of prescription drugs.

Google, based in Mountain View, California, was aware as early as 2003 that the shipment of prescription medicines to the US from outside the country is illegal, the Department of Justice said in a statement on Wednesday.

“We banned the advertising of prescription drugs in the US by Canadian pharmacies some time ago,” Google said in an e-mailed statement. “However, it’s obvious with hindsight that we shouldn’t have allowed these ads on Google in the first place. Given the extensive coverage this settlement has already received, we won’t be commenting further.”

Google announced in February 2010 that it would only accept US and Canadian ads from pharmacies certified by the National Association of Boards of Pharmacy’s Verified Internet Pharmacy Practice Sites program, known as VIPPS, and the Canadian International Pharmacy Association.

In December 2010, Google joined Microsoft Corp, Yahoo! Inc and other companies in helping establish a non-profit organisation to fight illegal Internet pharmacies. Counterfeit drug sales account for about $75 billion in global sales, the National Association of Boards of Pharmacy said at the time. About 1 per cent to 2 per cent of drugs in North America are counterfeit, according to the pharmacy group.

“The result of this investigation has been a fundamental transformation of Internet pharmacy advertising practices, significantly limiting promotion to US consumers by rogue online pharmacies,” said Kathleen Martin-Weis, acting director of the Food and Drug Administration’s Office of Criminal Investigations, in the statement.

Google said in May that it had set aside $500 million for the resolution of an investigation of its ad business.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Markets end flat
- Turbulence ahead for airlines despite oil price drop
- Weak rupee may bring cheer to NRIs, expats
- LIC buys PSU stocks, sells pvt sector blue-chips in Q4
- Banks may lower deposit rates as inflation eases: Report
  Read Business news in 
- Journey on, We are by Your Side. Click here to know more
- 2 Lac Apartments, 1 Lac House / Plots. Click here
- Benefits Upto Rs. 2.36 Lakhs on the Fully Loaded TJet Petrol.
- Watch The Film Here. Click here to know more..
- Leader in Passenger Car & Automobile Tyres. Click here
- 1 billion in saving for Unilever without any tangles.
- Learn How One City is Running on FOOD SCRAPS.
- One Partnership Endless Possibilities. Click here to know more
- Helping doctors detect diseases earlier, saving costs & extending lives.
- 36 Lakhs can get you a pool of Luxuries. Click here
- Which is the best plan for your daughter
- Check out the TRUE COLOURS of your Stocks, Now for FREE!
- One of the leading business schools in the world.Know More
Sorry, comments to this story are closed
Latest Messages
Table for Two
  Now available at Special price
  Rs.280/- Only

  Buy Now
BS POLL
UPA 2 has completed three years. How do you rate its performance?  Read the story
  Good
  Average
  Bad
Submit
Most Popular
Read
E-Mailed
Commented
   
- Renu Kohli: Rupee: depreciated tactics
- Mobile handset companies bet on Indian app makers
- RIL wants import-parity price for its gas
- Gold imports fall 32% on strict govt measures
- CBI arrests Jagan Andhra on alert
 
 More  
Tax Shastra
  Now available at Special price
  Rs. 360/- Only

  Buy Now
  Hot Searches  
 
Apalya |  Air India |  GAAR |  Agni  |  Solar eclipse |  Satyamev Jayate |  SRK |  Aamir Khan |  IPL |  Ertiga |  Sarfaesi Act |  Vodafone |  JP Morgan |  Transfer pricing |  Rupee |  Kingfisher Airlines |  Silver |  Provident Fund |  income tax refund |  iPhone |  Reliance Industries |  SEBI |  BSNL |  BSE |  NSE |  Mukesh Ambani |  Anil Ambani |  Infosys |  Pranab Mukherjee |  Sonia Gandhi |  Rahul Gandhi |  New Pension Scheme |  Reliance |  RBI |  GDP |  Gold |  Ratan Tata |  ICICI |  B-School |  Sensex |  Tax calculator |  Home Loan |  Personal Finance |  inflation |  oil prices |  Barack Obama |   
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World | General News
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us